Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of EUS/EBUS fine needle aspiration versus histology for PD-L1 staining in NSCLC
NL-OMON45681Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jul 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of nivolumab in non-small cell lung cancer (NSCLC), sponsored by University Medical Center Groningen. Primary endpoint: Agreement between cytology blocks and routine histology for PD-L1 staining. Started Jul 2017; status: active, not recruiting.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON45681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45681.